International Clinical Psychopharmacology

• Sender: owner-newjour@ccat.sas.upenn.edu

Subject: International Clinical Psychopharmacology
Date: Sat, 10 Jan 1998 12:33:22 -0500 (EST)

International Clinical Psychopharmacology

http://www.chapmanhall.com/in/default.html

ISSN:  0268-1315

International Clinical Psychopharmacology is a subscription-based
electronic version of the same title published six times a year by Rapid
Science Publishers.  Full-text is available to subscribers as PDF files.

International Clinical Psychopharmacology continues to maintain its high
standing in publishing research and clinical practice within the field.
This respected journal largely focuses on psychotropic drugs, covering
phase I-IV studies, clinical studies, side effects and epidemiology. With
regular volume indexes to assist further research and investigation, this
journal is an invaluable reference source.

                         
International Clinical Psychopharmacology attracts ever increasing
interests from the pharmaceutical industry. Much of the latest research
within psychopharmacology is published in the form of supplements to the
journal, and these undergo the same rigorous peer review as those in the
regular issues.  Supplements form part of the annual subscription, though
they are also available separately.

Throughout its eleven year history, International Clinical
Psychopharmacology has provided an essential link between research and
clinical practice throughout psychopharmacology.  Its fundamental aim is
to enhance our understanding of psychotropic drugs in health and disease.
To achieve this, the journal publishes the results of early phase I and II
studies, as well those of controlled clinical trials of psychotropic drugs
in phase III and IV. 

Research papers published in the journal are of the highest quality, and,
as such, influence clinical practice worldwide. 
                         
Supplements, which are included with the subscription, form an important
part of the journal. Recent supplements reflect the ever-increasing
interest that the journal has attracted. These have included reviews of
antidepressants and antipsychotics and proceedings of important
international meetings including recent ECNP and BAP conferences.
                         
All papers submitted are strictly peer reviewed.  There are no submission
or page charges for papers submitted to this journal. 

Recent Contents:

Response characteristics to antidepressants and placebo in post-traumatic
stress disorder: J.R.T Davidson, M.L Malik, S.N Sutherland, PP. 291-296

The dopamine hypothesis of schizophrenia: current status, future
prospects: P Willner, PP. 297-308

A 2-year study of sertraline in the treatment of obsessive-compulsive
disorder: S Rasmussen, E Hackett, E DuBoff, J Greist, A Halaris, L.M
Koran, M Liebowitz, R.B Lydiard, S McElroy, J Mendels , K O'Connor, PP. 
309-316

Moclobemide effects on prolactin plasma levels in healthy individuals: the
hormonal increase induced by a single dose is maintained during a 4-week
period of drug intake: M.F Juruena, M.L.N Pires, H.M Calil, PP. 317-321

A double-blind multicenter trial comparing sertraline and citalopram in
patients with major depression treated in general practice: L. Ekselius,
L. von Knorring, G. Eberhard, PP. 323-331

Long-term risperidone treatment in bipolar disorder: 6-month follow up: 
S.N Ghaemi, G.S Sachs, PP. 333-338

Serotonin syndrome - clomipramine too soon after moclobemide?: P.K. 
Gillman, PP. 339-342

AUTHOR INDEX - Direct link to PDF

CONTENTS PAGE - Direct link to PDF

Contact: 

jhelp@rapidcom.co.uk